Exercise therapy for chronic symptomatic peripheral artery disease: a clinical consensus document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases in collaboration with the European Society of Vascular Medicine and the European Society for Vascular Surgery

Mazzolai, L ORCID: https://orcid.org/0000-0001-9650-3822, Belch, J, Venermo, M ORCID: https://orcid.org/0000-0001-8814-0988, Aboyans, V ORCID: https://orcid.org/0000-0002-0322-9818, Brodmann, M, Bura-Rivière, A, Debus, S, Espinola-Klein, C ORCID: https://orcid.org/0000-0001-9243-1761, Harwood, AE ORCID: https://orcid.org/0000-0002-5745-2564, Hawley, JA, Lanzi, S ORCID: https://orcid.org/0000-0003-1089-6309, Madarič, J, Mahé, G, Malatesta, D, Schlager, O ORCID: https://orcid.org/0000-0001-6934-5355, Schmidt-Trucksäss, A, Seenan, C, Sillesen, H, Tew, GA and Visonà, A (2024) Exercise therapy for chronic symptomatic peripheral artery disease: a clinical consensus document of the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases in collaboration with the European Society of Vascular Medicine and the European Society for Vascular Surgery. Vasa - European Journal of Vascular Medicine, 53 (2). pp. 87-108. ISSN 0301-1526

Preview

Accepted Version Available under License In Copyright. Download (630kB) | Preview

Abstract

All guidelines worldwide strongly recommend exercise as a pillar in the management of patients affected by lower extremity peripheral artery disease (PAD). Exercise therapy in this setting presents different modalities, and a structured programme provides optimal results. This clinical consensus paper is intended to promote and assist the set up of comprehensive exercise programmes and best advice for patients with symptomatic chronic PAD. Different exercise training protocols specific for patients with PAD are presented. Data on patient assessment and outcome measures are described based on the current best evidence. The document ends by highlighting supervised exercise programme access disparities across Europe and the evidence gaps requiring further research.